The R&D Division is the scientific research arm of EDS, whose cutting-edge research helps provide the solid foundation of science and technology for the all products launched under the Elsie Genetics Division.
The focus of the R&D team is to collect and analyze data while implementing advanced technologies to develop new options in the fight against disease.
Currently, our team is focused on formulations targeting genes critical in the formation and progression of breast cancer. They will move forward with ovarian and prostate cancers in 2019.
Learn more about our research here